Cargando…

IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker

Insulin-like growth factor binding proteins (IGFBPs) play critical roles in carcinogenesis. This study assessed the impact of IGFBP6 on the progression of nasopharyngeal carcinoma (NPC). Using immunohistochemical analysis, we found that IGFBP6 was differentially expressed in primary malignant NPC ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qiuyan, Qin, Siyuan, Liu, Yang, Hong, Minghuang, Qian, Chao-Nan, Keller, Evan T., Zhang, Jian, Lu, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356544/ https://www.ncbi.nlm.nih.gov/pubmed/27623076 http://dx.doi.org/10.18632/oncotarget.11886

Ejemplares similares

Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes
por: Yang, Qi, et al.
Publicado: (2015)

CT‐IGFBP‐4 as a novel prognostic biomarker in acute heart failure
por: Konev, Alexey A., et al.
Publicado: (2020)

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

Distant Metastasis Risk Definition by Tumor Biomarkers Integrated Nomogram Approach for Locally Advanced Nasopharyngeal Carcinoma
por: Fan, Xinjuan, et al.
Publicado: (2019)

IGFBP2 function as a novel biomarker for active lupus nephritis
por: Li, Hui, et al.
Publicado: (2022)

p53R2 as a novel prognostic biomarker in nasopharyngeal carcinoma
por: Chen, Jiewei, et al.
Publicado: (2017)

DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients
por: Wu, Zeng-hong, et al.
Publicado: (2020)

Circulating IGFBP‐2: a novel biomarker for incident dementia
por: McGrath, Emer R., et al.
Publicado: (2019)

Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma
por: Feng, Xinwei, et al.
Publicado: (2017)

Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
por: Lee, Sung-Wei, et al.
Publicado: (2022)

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
por: Liu, Li-Ting, et al.
Publicado: (2018)

Intestinal Flora Disruption and Novel Biomarkers Associated With Nasopharyngeal Carcinoma
por: Jiang, Haiye, et al.
Publicado: (2019)

Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3
por: Yin, Li, et al.
Publicado: (2020)

Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the Literature
por: Islam, Kazi Anisha, et al.
Publicado: (2022)

Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma
por: Le, Thuy Ai Huyen, et al.
Publicado: (2022)

The prevalence and prevention of nasopharyngeal carcinoma in China
por: Cao, Su-Mei, et al.
Publicado: (2011)

Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
por: Wang, Haiwei, et al.
Publicado: (2022)

IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
por: Perez-Carbonell, Lucia, et al.
Publicado: (2014)

BCL6-SPECC1L: A Novel Fusion Gene in Nasopharyngeal Carcinoma
por: Fang, Shuo-Gui, et al.
Publicado: (2022)

Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma
por: Wen, Wen, et al.
Publicado: (2019)

Integrative Analysis Identified a 6-miRNA Prognostic Signature in Nasopharyngeal Carcinoma
por: Chen, Yunqin, et al.
Publicado: (2021)

A new prognostic histopathologic classification of nasopharyngeal carcinoma
por: Wang, Hai-Yun, et al.
Publicado: (2016)

Upregulation of circRNA_0000285 serves as a prognostic biomarker for nasopharyngeal carcinoma and is involved in radiosensitivity
por: Shuai, Mingxia, et al.
Publicado: (2018)

Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics
por: Li, Jianpei, et al.
Publicado: (2018)

MRI-based radiomics signature is a quantitative prognostic biomarker for nasopharyngeal carcinoma
por: Ming, Xue, et al.
Publicado: (2019)

Prognostic value of IGFBP2 in various cancers: a systematic review and meta‐analysis
por: Zhang, Biao, et al.
Publicado: (2022)

Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma
por: Cao, Jing-Yan, et al.
Publicado: (2010)

IGFBP-4: A promising biomarker for lung cancer
por: Nur, Savas Irem, et al.
Publicado: (2021)

Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma
por: Tu, Bo, et al.
Publicado: (2022)

Ferroptosis-related gene ATG5 is a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
por: Shi, Ming, et al.
Publicado: (2022)

Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection
por: Li, Xiaoyun, et al.
Publicado: (2020)

Molecular Decision Tree Algorithms Predict Individual Recurrence Pattern for Locally Advanced Nasopharyngeal Carcinoma
por: Cai, Hongmin, et al.
Publicado: (2019)

Serum proteomics identify potential biomarkers for nasopharyngeal carcinoma sensitivity to radiotherapy
por: Zhang, Guangying, et al.
Publicado: (2019)

Gene Signatures and Prognostic Values of m(6)A Genes in Nasopharyngeal Carcinoma
por: Lu, Shanshan, et al.
Publicado: (2020)

Diagnostic and Prognostic Indications of Nasopharyngeal Carcinoma
por: E. A. R., Engku Nur Syafirah, et al.
Publicado: (2020)

Prognostic factors in metastatic nasopharyngeal carcinoma
por: Toumi, Nabil, et al.
Publicado: (2020)

Expanding the scope of candidate prognostic marker IGFBP2 in glioblastoma
por: Lindström, Mikael S.
Publicado: (2019)

A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
por: He, Jian, et al.
Publicado: (2022)

IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis
por: Liso, Arcangelo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jggful8rqmg50vhcdlccc324dj